相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Procyanidin B2 inhibits angiogenesis and cell growth in oral squamous cell carcinoma cells through the vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway
Qiurong Sun et al.
BIOENGINEERED (2022)
PDLIM2: Signaling pathways and functions in cancer suppression and host immunity
Zong Sheng Guo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
PDLIM2 prevents the malignant phenotype of hepatocellular carcinoma cells by negatively regulating β-catenin
Xiaoming Jiang et al.
CANCER GENE THERAPY (2021)
RAD51AP1 promotes progression of ovarian cancer via TGF-β/Smad signalling pathway
Hongyu Zhao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Lidocaine inhibits the metastatic potential of ovarian cancer by blocking NaV1.5-mediated EMT and FAK/Paxillin signaling pathway
Chang Liu et al.
CANCER MEDICINE (2021)
Targeting Myeloid-Derived Suppressor Cells in Ovarian Cancer
Seiji Mabuchi et al.
CELLS (2021)
Metalloproteinases in Ovarian Cancer
Preston Carey et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells
Wookyeom Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Ovarian Cancer Immunotherapy and Personalized Medicine
Susan Morand et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
PDLIM2 Suppression Inhibit Proliferation and Metastasis in Kidney Cancer
Hyeong-Dong Yuk et al.
CANCERS (2021)
Ovarian-Cancer-Associated Extracellular Vesicles: Microenvironmental Regulation and Potential Clinical Applications
Priyakshi Kalita-de Croft et al.
CELLS (2021)
Epithelial-Mesenchymal Transition Predicts Survival in Oral Squamous Cell Carcinoma
Chimi Wangmo et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Inhibiting of self-renewal, migration and invasion of ovarian cancer stem cells by blocking TGF-β pathway
Haiyan Wen et al.
PLOS ONE (2020)
PDLIM2 acts as a cancer suppressor gene in non-small cell lung cancer via the down regulation of NF-κB signaling
Hongyang Shi et al.
MOLECULAR AND CELLULAR PROBES (2020)
Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter study
Helmut Plett et al.
GYNECOLOGIC ONCOLOGY (2020)
TOP2A Promotes Tumorigenesis of High-grade Serous Ovarian Cancer by Regulating the TGF-β/Smad Pathway
Yan Gao et al.
JOURNAL OF CANCER (2020)
PDLIM2 Is a Marker of Adhesion and β-Catenin Activity in Triple-Negative Breast Cancer
Orla T. Cox et al.
CANCER RESEARCH (2019)
TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling
Lu Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The role of TGFβ in hematopoiesis and myeloid disorders
Alex Bataller et al.
LEUKEMIA (2019)
Overexpression of mircoRNA-137 inhibits cervical cancer cell invasion, migration and epithelial-mesenchymal transition by suppressing the TGF-/smad pathway via binding to GREM1
Hui Miao et al.
CANCER CELL INTERNATIONAL (2019)
C1 CAGE detects transcription start sites and enhancer activity at single-cell resolution
Tsukasa Kouno et al.
NATURE COMMUNICATIONS (2019)
Epigenetic repression of PDZ-LIM domain-containing protein 2 promotes ovarian cancer via NOS2-derived nitric oxide signaling
Linjie Zhao et al.
ONCOTARGET (2016)